Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks

被引：52

作者：

Gadde, Kishore M.

Allison, David B.

机构：

[1] Duke Univ, Med Ctr, Obes Clin Trials Program, Durham, NC 27710 USA

[2] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA

[3] Univ Alabama Birmingham, Clin Nutr Res Ctr, Birmingham, AL 35294 USA

来源：

CIRCULATION | 2006年 / 114卷 / 09期

关键词：

obesity; drugs; pharmacology;

D O I：

10.1161/CIRCULATIONAHA.105.596130

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：974 / 984

页数：11

共 102 条

[1]

*ABB LAB, 2005, PRESCR INF MER SIB H

[2] Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies [J].

Allison, DB ;

Zannolli, R ;

Faith, MS ;

Heo, M ;

Pietrobelli, A ;

VanItallie, TB ;

Pi-Sunyer, FX ;

Heymsfield, SB .

INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (06) :603-611

[3] Annual deaths attributable to obesity in the United States [J].

Allison, DB ;

Fontaine, KR ;

Manson, JE ;

Stevens, J ;

VanItallie, TB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1530-1538

[4] Bupropion SR enhances weight loss: A 48-week double-blind, placebo-controlled trial [J].

Anderson, JW ;

Greenway, FL ;

Fujioka, K ;

Gadde, KM ;

McKenney, J ;

O'Neil, PM .

OBESITY RESEARCH, 2002, 10 (07) :633-641

[5]

[Anonymous], 1998, NIH PUBL

[6]

ANTHENELLI RM, 2004, 6 ANN C SRNT EUR OCT

[7] Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine [J].

Apfelbaum, M ;

Vague, P ;

Ziegler, O ;

Hanotin, C ;

Thomas, F ;

Leutenegger, E .

AMERICAN JOURNAL OF MEDICINE, 1999, 106 (02) :179-184

[8] Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors [J].

Arnone, M ;

Maruani, J ;

Chaperon, F ;

Thiebot, MH ;

Poncelet, M ;

Soubrie, P ;

LeFur, G .

PSYCHOPHARMACOLOGY, 1997, 132 (01) :104-106

[9] The efficacy and safety of sibutramine for weight loss - A systematic review [J].

Arterburn, DE ;

Crane, PK ;

Veenstra, DL .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) :994-1003

[10]

Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x

← 1 2 3 4 5 6 7 8 9 10 →